Skip to main content
Top

Drugs

Issue 6/2019

Content (14 Articles)

Drug Resistance During HIV Pre-Exposure Prophylaxis

Kevin M. Gibas, Polly van den Berg, Victoria E. Powell, Douglas S. Krakower

Distinct Profiles on Subjective and Objective Adherence Measures in Patients Prescribed Antidepressants

Hans Wouters, Didi Rhebergen, Marcia Vervloet, Antoine Egberts, Katja Taxis, Liset van Dijk, Helga Gardarsdottir

Tofacitinib: A Review in Psoriatic Arthritis

Julia Paik, Emma D. Deeks

Lenvatinib: A Review in Hepatocellular Carcinoma

Zaina T. Al-Salama, Yahiya Y. Syed, Lesley J. Scott

Relugolix: First Global Approval

Anthony Markham

Correction to: Revefenacin: First Global Approval

  • Open Access
  • Correction

Young-A Heo

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images